HA-coated Chitosan Nanoparticles For CD44-mediated Nucleic Acid Delivery.
Abdulaziz Almalik, P. Day, N. Tirelli
Published 2013 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
CD44, the main receptor of hyaluronic acid (HA), is overexpressed in several pathological conditions and therefore can be seen as an interesting target for therapeutic intervention. Here, an approach using HA-coated chitosan (CS)-triphosphate (TPP) nanoparticles is investigated, using CS with different molecular weight (25 and 684 kDa), which influences HA presentation, and enzymatic and pH stability. In a study of nuclease stability, post-digestion of nanoparticles with chitosanase reveals that pDNA is at least partially degraded by DNAse; this may suggest that literature results overestimate the polyplex stability against nucleases. Using cells with a significantly different CD44 expression (RAW 264.7 macrophages-high levels; K562 leukemia cells-low levels; Kelly neuroblastoma cells-absent), the selectivity of CD44-mediated transfection is proven. Further, using luciferase pDNA and then later anti-luc siRNA, low MW CS-based nanoparticles show the best results despite a lower internalization efficiency; this effect is ascribed to a more efficient endosomal disruption and nucleic acid de-complexation.
This paper references
CD44: a validated target for improved delivery of cancer therapeutics
S. Ghosh (2012)
Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation.
M. Huang (2005)
Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery.
P. Chan (2007)
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
X. Liu (2007)
Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
N. Gross (1997)
Expression of CD44 is repressed in neuroblastoma cells.
E. Shtivelman (1991)
Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response.
Yifat Glucksam-Galnoy (2012)
Toxicity of cationic lipids and cationic polymers in gene delivery.
Hongtao Lv (2006)
Silencing human genetic diseases with oligonucleotide-based therapies
T. Martínez (2013)
A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity
D. Fischer (2004)
Functionalization of Chitosan via Atom Transfer Radical Polymerization for Gene Delivery
Yuan Ping (2010)
Chitosan/TPP and Chitosan/TPP-hyaluronic Acid Nanoparticles: Systematic Optimisation of the Preparative Process and Preliminary Biological Evaluation
A. Nasti (2009)
Design of biocompatible chitosan microgels for targeted pH-mediated intracellular release of cancer therapeutics.
H. Zhang (2006)
Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy.
Sania Mansouri (2004)
Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
A. Tong (2008)
Plasma membrane targeting of SNAP-25 increases its local concentration and is necessary for SNARE complex formation and regulated exocytosis.
D. Koticha (2002)
Long-Circulating Nanopartides Bearing Heparin or Dextran Covalently Bound to Poly(Methyl Methacrylate)
C. Passirani (2004)
Nanostructured hyaluronic acid-based materials for active delivery to cancer
D. Ossipov (2010)
Towards safe, non-viral therapeutic gene expression in humans
D. Glover (2005)
Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells
Laura Contreras-Ruiz (2011)
CD44 is a phagocytic receptor.
Eric Vachon (2006)
Water-Soluble and Low Molecular Weight Chitosan-Based Plasmid DNA Delivery
M. Lee (2004)
Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.
Shuying Gao (2005)
Therapeutic and prophylactic DNA vaccines for HIV-1
L. Ramirez (2013)
Gene expression profiling in chemoresistant variants of three cell lines of different origin.
A. Johnsson (2005)
In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer
C. K. Goldman (1997)
Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles.
Abdulaziz Almalik (2013)
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
H. Mao (2001)
Gene therapy for autoimmune diseases: quo vadis?
Y. Chernajovsky (2004)
Chitosan-based formulations for delivery of DNA and siRNA.
S. Mao (2010)
Glycosylation of CD44 negatively regulates its recognition of hyaluronan
S. Katoh (1995)
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
M. de la Fuente (2008)
Biological barriers to therapy with antisense and siRNA oligonucleotides.
R. Juliano (2009)
Macrophages and fibroblasts during inflammation, tissue damage and organ injury.
T. Glaros (2009)
Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine.
Peisheng Xu (2009)
Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model.
N. M. Zaki (2011)
Hyaluronic Acid/Chitosan-g-Poly(ethylene glycol) Nanoparticles for Gene Therapy: An Application for pDNA and siRNA Delivery
M. Raviña (2010)
Gene delivery by lipoplexes and polyplexes.
C. Tros de Ilarduya (2010)
Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery
D. Lee (2006)
Comparative adhesion of human haemopoietic cell lines to extracellular matrix components, bone marrow stromal and endothelial cultures
M. Turner (1998)
The Transmembrane Domains of L-selectin and CD44 Regulate Receptor Cell Surface Positioning and Leukocyte Adhesion under Flow*
K. Buscher (2010)
Intravenous, non-viral RNAi gene therapy of brain cancer
W. Pardridge (2004)
Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan/DNA nanoparticles.
T. Kim (2006)
The promises and pitfalls of RNA-interference-based therapeutics
D. Castanotto (2009)
Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes.
S. Katoh (1999)
Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting.
Shuying Gao (2003)
This paper is referenced by
Mannosylation Allows for Synergic (CD44/C-Type Lectin) Uptake of Hyaluronic Acid Nanoparticles in Dendritic Cells, but Only upon Correct Ligand Presentation.
A. Gennari (2016)
Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
M. A. Kalam (2016)
Nanoparticle delivery of stable miR-199a-5p agomir improves the osteogenesis of human mesenchymal stem cells via the HIF1a pathway.
X. Chen (2015)
Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta
Rong-Hui Deng (2018)
Tailoring the Surface of a Gene Delivery Vector with Carboxymethylated Dextran: A Systematic Analysis.
Charles Fortier (2015)
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia.
Breanne Landry (2015)
Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitis C by RNA interference.
J. Torrecilla (2015)
Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: in vitro and in vivo investigations.
Sobiya Zafar (2014)
Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells.
Vivek D Badwaik (2016)
1H‐NMR‐based Metabolomics Studies of the Toxicity of Mesoporous Carbon Nanoparticles in Zebrafish (Danio rerio)
Ganesan Raja (2017)
Saccharide‐based nanocarriers for targeted therapeutic and diagnostic applications
Vincent Mukwaya (2019)
CD44 targeted delivery of siRNA by using HA‐decorated nanotechnologies for KRAS silencing in cancer treatment
Annalisa Tirella (2019)
Cellular responses of hyaluronic acid-coated chitosan nanoparticles.
Abdulaziz M Almalik (2018)
On the Formation and Stability of Chitosan/Hyaluronan-Based Complex Coacervates
Franco Furlani (2020)
HA-decorated nanoparticles as tumour-targeting nucleic acids carriers
J. L. Rosa (2015)
Targeted delivery of a short antimicrobial peptide against CD44-overexpressing tumor cells using hyaluronic acid-coated chitosan nanoparticles: An in vitro study
Vahid Taghipour-Sabzevar (2020)
Receptor‐Targeted Drug Delivery and the (Many) Problems We Know of: The Case of CD44 and Hyaluronic Acid
Julio M. Rios de la Rosa (2018)
Concepts for Developing Physical Gels of Chitosan and of Chitosan Derivatives
Pasquale Sacco (2018)
Development and characterisation of chondroitin sulfate‐ and hyaluronic acid‐incorporated sorbitan ester nanoparticles as gene delivery systems
I. Fernandez-Piñeiro (2018)
Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity
V. Quagliariello (2018)
Chitosan/Hyaluronic Acid Nanoparticles: Rational Design Revisited for RNA Delivery.
E. Lallana (2017)
Binding and Internalization in Receptor-Targeted Carriers: The Complex Role of CD44 in the Uptake of Hyaluronic Acid-Based Nanoparticles (siRNA Delivery).
Julio M Rios de la Rosa (2019)
The different ways to chitosan/hyaluronic acid nanoparticles: templated vs direct complexation. Influence of particle preparation on morphology, cell uptake and silencing efficiency
A. Gennari (2019)
Hyaluronic acid decorated lipid nanocarrier for MDR modulation and CD-44 targeting in colon adenocarcinoma.
Lalit Mohan Singh Negi (2015)
Targeted Delivery of siRNA Therapeutics to Malignant Tumors
Qixin Leng (2017)
Développement de complexes polyélectrolytes à base d’acide hyaluronique et de chitosane pour la livraison d’ARN messager
Ousamah Younoss Soliman (2018)
Synergistic clearance of intracellular pathogens by hyaluronan-streptomycin micelles encapsulated with rapamycin.
Yuanhao Qiu (2019)
New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase
V. Quagliariello (2016)
BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia.
X. Zhu (2014)
The CD44‐Mediated Uptake of Hyaluronic Acid‐Based Carriers in Macrophages
Julio M. Rios de la Rosa (2017)
The Microfluidic Technique and the Manufacturing of Polysaccharide Nanoparticles
E. Chiesa (2018)
Splenic gene delivery system using self-assembling nano-complex with phosphatidylserine analog.
Tomoaki Kurosaki (2015)See more